Editorial Commentary
The time to prevent infectious complications is now: why transperineal prostate biopsies should be the new gold standard worldwide
Translational Andrology and Urology
2025;
14
(5)
:1147-1149
.
(30 May 2025)
Neoadjuvant strategies in locally advanced prostate cancer: progress or premature?
Translational Andrology and Urology
2025;
14
(5)
:1150-1151
.
(30 May 2025)
Let food be thy healer, and movement thy shield, before the scalpel entering the field—praise for a pre-prostatectomy diet and exercise program
Translational Andrology and Urology
2025;
14
(5)
:1152-1154
.
(30 May 2025)
Neoadjuvant chemotherapy for muscle-invasive bladder cancer with variant histology and/or divergent differentiation
Translational Andrology and Urology
2025;
14
(5)
:1155-1157
.
(30 May 2025)
Efficacy of prophylactic use of biologic mesh in ileal conduit: insights from the PUBMIC trial
Translational Andrology and Urology
2025;
14
(5)
:1158-1159
.
(30 May 2025)
Patient-centered outcomes and preference between darolutamide and enzalutamide: insights from the ODENZA trial
Translational Andrology and Urology
2025;
14
(5)
:1160-1164
.
(30 May 2025)
Biopsy-free radical prostatectomy for prostate cancer—modern reality or pipe dream?
Translational Andrology and Urology
2025;
14
(5)
:1165-1168
.
(30 May 2025)
Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinations
Translational Andrology and Urology
2025;
14
(5)
:1169-1173
.
(30 May 2025)
Shifting paradigms in the treatment of small renal masses
Translational Andrology and Urology
2025;
14
(5)
:1174-1181
.
(30 May 2025)
Optimizing salvage radiotherapy in prostate cancer: the emerging role of prostate-specific membrane antigen positron emission tomography/computed tomography
Translational Andrology and Urology
2025;
14
(5)
:1182-1186
.
(30 May 2025)
Variant histology muscle invasive bladder cancer should not preclude neoadjuvant chemotherapy before cystectomy
Translational Andrology and Urology
2025;
14
(5)
:1187-1189
.
(30 May 2025)
Original Article
High intratumoral heterogeneity in clear cell renal cell carcinoma is associated with reduced immune response and survival
Translational Andrology and Urology
2025;
14
(5)
:1190-1203
.
(30 May 2025)
Clinical significance of urine-based automated detection of GSTP1 methylation for the diagnosis of suspected prostate cancer patients
Translational Andrology and Urology
2025;
14
(5)
:1204-1213
.
(30 May 2025)
Migrasome-related lncRNAs predict prognosis and immune response of clear cell renal cell carcinoma
Translational Andrology and Urology
2025;
14
(5)
:1214-1229
.
(30 May 2025)
Knowledge, attitude, and practice of kidney transplant patients regarding post-transplant complications: a cross-sectional study
Translational Andrology and Urology
2025;
14
(5)
:1230-1237
.
(30 May 2025)
Global epidemiological trends in prostate cancer burden: a comprehensive analysis from Global Burden of Disease Study 2021
Translational Andrology and Urology
2025;
14
(5)
:1238-1252
.
(30 May 2025)
Mirabegron efficacy as medical expulsive therapy for distal ureteral stones: a systematic review of the literature, meta-analysis and trial sequential analysis
Translational Andrology and Urology
2025;
14
(5)
:1253-1260
.
(30 May 2025)
GreenLight photoselective laser vaporisation versus transurethral resection of the prostate for large prostates: systematic review and meta-analysis
Translational Andrology and Urology
2025;
14
(5)
:1261-1272
.
(30 May 2025)
Association between dietary calcium intake and benign prostatic hyperplasia: a population-based result from NHANES 2003 to 2008
Translational Andrology and Urology
2025;
14
(5)
:1273-1282
.
(30 May 2025)
Correlation between lifestyle choices, dietary factors, and the risk of adult urolithiasis: insights from a systematic review and meta-analysis
Translational Andrology and Urology
2025;
14
(5)
:1283-1294
.
(30 May 2025)
A cross-sectional survey of experiences and outcomes of using testosterone replacement therapy in UK men
Translational Andrology and Urology
2025;
14
(5)
:1295-1307
.
(30 May 2025)
Waiting in line for a fusion prostate biopsy—what does a patient know, fear and expect
Translational Andrology and Urology
2025;
14
(5)
:1308-1314
.
(30 May 2025)
Impact of suction ureteral access sheath in ureteroscopy/retrograde intrarenal surgery: a systematic review and meta-analysis
Translational Andrology and Urology
2025;
14
(5)
:1315-1326
.
(30 May 2025)
Identification of core genes in acute kidney injury: evidence from multi-omics human transcriptomic data and in vivo models
Translational Andrology and Urology
2025;
14
(5)
:1327-1347
.
(30 May 2025)
Improving outcomes in robot-assisted urologic oncology surgery using a perioperative electronic health program
Translational Andrology and Urology
2025;
14
(5)
:1348-1354
.
(30 May 2025)
Financial considerations among adult men undergoing vasectomy: cost analysis and modeling of outpatient costs associated with vasectomy
Translational Andrology and Urology
2025;
14
(5)
:1355-1362
.
(30 May 2025)
Analysis of the burden of disease for male infertility globally and in China from 1990 to 2021
Translational Andrology and Urology
2025;
14
(5)
:1363-1378
.
(30 May 2025)
A prospective study to determine the safety and feasibility of opioid-free discharge after percutaneous nephrolithotomy
Translational Andrology and Urology
2025;
14
(5)
:1379-1390
.
(30 May 2025)
Rising incidence and clinical impact of kidney cancer in China and worldwide: a call for targeted prevention, early diagnosis, and equitable treatment
Translational Andrology and Urology
2025;
14
(5)
:1391-1407
.
(30 May 2025)
Age-related changes in lncRNA expression in sperm
Translational Andrology and Urology
2025;
14
(5)
:1408-1417
.
(30 May 2025)
Comparison of prostate cancer detection rates and complications between transrectal ultrasound-guided transperineal and transrectal biopsies: a systematic review and meta-analysis
Translational Andrology and Urology
2025;
14
(5)
:1418-1428
.
(30 May 2025)
Fisetin-mediated PPAR-γ upregulation: a novel therapeutic approach for corpus cavernosum smooth-muscle-cell apoptosis and restoration of erectile function after cavernous nerve injury
Translational Andrology and Urology
2025;
14
(5)
:1429-1443
.
(30 May 2025)
Clinical outcomes of modified partial cystectomy in muscle-invasive bladder cancer: balancing tumor control and quality of life
Translational Andrology and Urology
2025;
14
(5)
:1444-1455
.
(30 May 2025)
Association of sperm DNA fragmentation with higher miscarriage rates in non-male factor infertility reproductive cycles
Translational Andrology and Urology
2025;
14
(5)
:1456-1465
.
(30 May 2025)
Surgical Technique
Total periurethral reconstruction with preservation of “Hood” structures promotes early recovery of urinary continence in extraperitoneal single-port robot-assisted radical prostatectomy
Translational Andrology and Urology
2025;
14
(5)
:1466-1475
.
(30 May 2025)
Review Article
Adjustable continence therapy for men (ProACTTM): systematic review and compendium of adverse events
Translational Andrology and Urology
2025;
14
(5)
:1476-1483
.
(30 May 2025)
Magnetic resonance imaging of paraurethral and paravaginal lesion: relevant diagnoses, key findings and surgical correlation
Translational Andrology and Urology
2025;
14
(5)
:1484-1502
.
(30 May 2025)
